Roth Capital raised the firm’s price target on Calix (CALX) to $85 from $69 and keeps a Buy rating on the shares following what the firm calls “another solid beat and raise” report for Q3. Broad-based demand and RPO strength is expected to continue into 2026, in part enabled by the imminently commercializing third gen platform, says the analyst, who sees Calix entering “a potential phase of multiple expansion.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CALX:
